Linda Petrone1, Valentina Vanini1, Elisa Petruccioli1, Giuseppe Maria Ettorre2, Elisa Busi Rizzi3, Vincenzo Schininà3, Enrico Girardi4, Alessandra Ludovisi5, María Ángeles Gómez-Morales5, Edoardo Pozio5, Antonella Teggi6, Delia Goletti7. 1. Translational Research Unit, Department of Epidemiology and Preclinical Research, "L. Spallanzani" National Institute for Infectious Diseases (INMI), Rome, Italy. 2. Unit of Surgery and Transplantation, "Interaziendale" Department P.O.I.T., Polo Ospedaliero Interaziendale San Camillo-INMI Lazzaro Spallanzani, Rome, Italy. 3. Department of Radiology, "L. Spallanzani" National Institute for Infectious Diseases (INMI), Rome, Italy. 4. Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases (INMI), Rome, Italy. 5. Department of Infectious, Parasitic and Immunomediated Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy. 6. Department of Infectious and Tropical Diseases, Sant'Andrea Hospital University of Rome"Sapienza", Rome, Italy. 7. Translational Research Unit, Department of Epidemiology and Preclinical Research, "L. Spallanzani" National Institute for Infectious Diseases (INMI), Rome, Italy. Electronic address: delia.goletti@inmi.it.
Abstract
OBJECTIVES: Human Cystic Echinococcosis (CE) is estimated in 2-3 million global cases. CE diagnosis and clinical management are based on imaging and serology, which lacks sensitivity and does not provide cyst stage information. This study aimed to evaluate tools for improving diagnosis by analysing the Interleukin (IL)-4-response to Antigen B (AgB) of Echinococcus granulosus. METHODS: Whole blood (WB) and peripheral blood mononuclear cells were stimulated with AgB. IL-4 levels were measured by enzyme-linked immunosorbent assay. RESULTS: WB 1-day stimulation resulted the best experimental condition for evaluating AgB IL-4-response. IL-4 levels were significantly higher in CE patients than healthy donors (p ≤ 0.0001). A ROC analysis showed significant area under the curve (AUC) results (AUC, 0.85; p = 0.0001) identifying an IL-4 level cut-off point ≥0.39 pg/mL which predicted CE with 71.4% sensitivity and 93.3% specificity. Moreover, we found that IL-4 levels were significantly increased in patients with active cysts compared to those with inactive cysts (p ≤ 0.0001). ROC analysis showed significant AUC results (0.94; p = 0.0001) with a cut-off point of 4.6 pg/mL which predicted active cysts with 84.6% sensitivity and 92% specificity. CONCLUSIONS: We found immunological correlates associated with CE and biological cyst activity.
OBJECTIVES:HumanCystic Echinococcosis (CE) is estimated in 2-3 million global cases. CE diagnosis and clinical management are based on imaging and serology, which lacks sensitivity and does not provide cyst stage information. This study aimed to evaluate tools for improving diagnosis by analysing the Interleukin (IL)-4-response to Antigen B (AgB) of Echinococcus granulosus. METHODS: Whole blood (WB) and peripheral blood mononuclear cells were stimulated with AgB. IL-4 levels were measured by enzyme-linked immunosorbent assay. RESULTS: WB 1-day stimulation resulted the best experimental condition for evaluating AgB IL-4-response. IL-4 levels were significantly higher in CE patients than healthy donors (p ≤ 0.0001). A ROC analysis showed significant area under the curve (AUC) results (AUC, 0.85; p = 0.0001) identifying an IL-4 level cut-off point ≥0.39 pg/mL which predicted CE with 71.4% sensitivity and 93.3% specificity. Moreover, we found that IL-4 levels were significantly increased in patients with active cysts compared to those with inactive cysts (p ≤ 0.0001). ROC analysis showed significant AUC results (0.94; p = 0.0001) with a cut-off point of 4.6 pg/mL which predicted active cysts with 84.6% sensitivity and 92% specificity. CONCLUSIONS: We found immunological correlates associated with CE and biological cyst activity.
Authors: Giovanni Matera; Maria Teresa Loria; Cinzia Peronace; Tatiana Catanzariti; Pio Settembre; Aida Giancotti; Angelo G Lamberti; Giorgio S Barreca; Luisa Galati; Gessica Dodaro; Maria Mazzitelli; Alessio Strazzulla; Carlo Torti; Angela Quirino; Maria Carla Liberto; Alfredo Focà Journal: Mediators Inflamm Date: 2018-01-14 Impact factor: 4.711
Authors: L Petrone; V Vanini; M Amicosante; A Corpolongo; M A Gomez Morales; A Ludovisi; G Ippolito; E Pozio; A Teggi; D Goletti Journal: Parasite Immunol Date: 2017-12 Impact factor: 2.280
Authors: Paula I Seoane; Dominik Rückerl; Cecilia Casaravilla; Anabella A Barrios; Álvaro Pittini; Andrew S MacDonald; Judith E Allen; Alvaro Díaz Journal: Sci Rep Date: 2016-12-14 Impact factor: 4.379
Authors: Ana Hernández-González; Carlos Sánchez-Ovejero; Raúl Manzano-Román; María González Sánchez; José Manuel Delgado; Teresa Pardo-García; Francisco Soriano-Gálvez; Okan Akhan; Carmen M Cretu; Kamenna Vutova; Francesca Tamarozzi; Mara Mariconti; Enrico Brunetti; Ambra Vola; Massimo Fabiani; Adriano Casulli; Mar Siles-Lucas Journal: PLoS Negl Trop Dis Date: 2018-09-06
Authors: Linda Petrone; Werner C Albrich; Francesca Tamarozzi; Manuel Frischknecht; Maria Angeles Gomez-Morales; Antonella Teggi; Matthias Hoffmann; Delia Goletti Journal: Parasite Immunol Date: 2020-02-07 Impact factor: 2.280
Authors: Federica Fratini; F Tamarozzi; G Macchia; L Bertuccini; M Mariconti; C Birago; A Iriarte; E Brunetti; C M Cretu; O Akhan; M Siles-Lucas; A Díaz; Adriano Casulli Journal: PLoS Negl Trop Dis Date: 2020-10-05